Literature DB >> 6185953

Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen.

A R Neurath, S B Kent, N Strick.   

Abstract

We predicted the localization of a major hepatitis B surface antigen (HBsAg) determinant within residues 135-155 [Neurath, A.R., Strick, N. & Oleszko, W.R. (1981) J. Virol. Methods 3, 115-125]. A peptide corresponding to this sequence (P135-155) was synthesized, linked to macromolecular carriers, and used to immunize rabbits. In accordance with published data on shorter peptides within the same amino acid sequence, antibodies to HBsAg were elicited. A detailed analysis of the immune response to P135-155 revealed the following: A heterogeneous population of IgG and IgM antibodies reacting with P135-155 was detected in the antisera by a variety of radioimmunoassays and enzyme-linked fluorescence immunoassays. Only a subpopulation of these antibodies reacted with HBsAg. The equilibrium constant (K) for the reaction of the antibodies with HBsAg (K = 4 X 10(5) M-1) was approximately two orders of magnitude lower than K for the reaction with P135-155 and was below K for the reaction between HBsAg and antibodies elicited by HBsAg (K greater than 10(7) M-1). Preimmunization with P135-155 did not result in an enhanced response to subsequent immunization with HBsAg. Peptides more accurately mimicking determinants on HBsAg may have to be synthesized for possible application in antiviral prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185953      PMCID: PMC347451          DOI: 10.1073/pnas.79.24.7871

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Complete nucleotide sequence of SV40 DNA.

Authors:  W Fiers; R Contreras; G Haegemann; R Rogiers; A Van de Voorde; H Van Heuverswyn; J Van Herreweghe; G Volckaert; M Ysebaert
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

2.  Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product.

Authors:  J G Sutcliffe; T M Shinnick; N Green; F T Liu; H L Niman; R A Lerner
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

3.  Antigenic sites related to human serum proteins in HBsAg: isolation from normal human serum of a high-molecular-weight glycoprotein reacting with antialbumin.

Authors:  A R Neurath; N Strick; C Y Huang; A M Prince
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

4.  Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization.

Authors:  R J Massey; G Schochetman
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

5.  Structure of the glycoprotein gene in rabies virus.

Authors:  A Anilionis; W H Wunner; P J Curtis
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

6.  Automated enzyme-linked fluorescence immunoassays for antiviral antibodies: a test for anti-HBs.

Authors:  A R Neurath; N Strick; S Goodman
Journal:  J Virol Methods       Date:  1982-05       Impact factor: 2.014

7.  Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli.

Authors:  H Küpper; W Keller; C Kurz; S Forss; H Schaller; R Franze; K Strohmaier; O Marquardt; V G Zaslavsky; P H Hofschneider
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

8.  Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product.

Authors:  A P Czernilofsky; A D Levinson; H E Varmus; J M Bishop; E Tischer; H M Goodman
Journal:  Nature       Date:  1980-09-18       Impact factor: 49.962

9.  Antibodies as immunological probes for studying the denaturation of HBsAg.

Authors:  A R Neurath; N Strick
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

10.  Enzyme-linked fluorescence immunoassays using beta-galactosidase and antibodies covalently bound to polystyrene plates.

Authors:  A R Neurath; N Strick
Journal:  J Virol Methods       Date:  1981-10       Impact factor: 2.014

View more
  9 in total

1.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

2.  Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.

Authors:  C O Jacob; M Sela; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

3.  Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.

Authors:  G Borisova; B Arya; A Dislers; O Borschukova; V Tsibinogin; D Skrastina; M A Eldarov; P Pumpens; K G Skryabin; E Grens
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 4.  Hepatitis B virus infection. Current concepts of chronicity and immunity.

Authors:  G N Vyas; H E Blum
Journal:  West J Med       Date:  1984-05

5.  Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.

Authors:  N Ogata; L Ostberg; P H Ehrlich; D C Wong; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Hepatitis B viral antigenic structure: signature analysis by monoclonal radioimmunoassays.

Authors:  J R Wands; M A Wong; J Shorey; R D Brown; R A Marciniak; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Specific targeting of membrane nodulins to the bacteroid-enclosing compartment in soybean nodules.

Authors:  M G Fortin; M Zelechowska; D P Verma
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

8.  On the meaning of affinity limits in B-cell epitope prediction for antipeptide antibody-mediated immunity.

Authors:  Salvador Eugenio C Caoili
Journal:  Adv Bioinformatics       Date:  2012-11-14

9.  Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.

Authors:  Joel R Haynes; Janet Cunningham; Adolph von Seefried; Michael Lennick; Robert T Garvin; Shi-Hsiang Shen
Journal:  Biotechnology (N Y)       Date:  1986
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.